REGENHU SA
REGENHU SA is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series C+.
About REGENHU SA
REGENHU SA is a startup based in Switzerland. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences.
REGENHU SA is a Swiss medtech company that develops and manufactures 3D bioprinting instruments and accompanying software (R-GEN series and SHAPER) for creating tissue models, human skin equivalents, tablet formulations, and cellular models for drug discovery. Their platforms combine multiple printing technologies to support biofabrication, personalized medicine development, and pharmaceutical R&D applications.
Explore REGENHU SA's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.